Thermo Fisher Scientific INC (TMO) Holder Pictet Asset Management LTD Lifted Position

June 21, 2018 - By James Guidry

Thermo Fisher Scientific Inc. (NYSE:TMO) LogoInvestors sentiment decreased to 0.86 in Q1 2018. Its down 0.05, from 0.91 in 2017Q4. It dropped, as 42 investors sold TMO shares while 444 reduced holdings. 119 funds opened positions while 301 raised stakes. 331.98 million shares or 1.09% less from 335.65 million shares in 2017Q4 were reported. Viking Glob Investors Ltd Partnership owns 864,681 shares or 1.08% of their US portfolio. Moreover, Employees Retirement System Of Texas has 0.11% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 39,100 shares. Argent Trust holds 11,387 shares. The New York-based Cibc Ww Mkts has invested 0.16% in Thermo Fisher Scientific Inc. (NYSE:TMO). Ssi Management holds 1,787 shares or 0.03% of its portfolio. Macquarie Grp Ltd holds 215,312 shares. Alphaone Inv Ltd Liability Co invested in 838 shares or 0.05% of the stock. Orrstown Incorporated holds 0.05% or 200 shares. Piedmont Inv Advisors Ltd Liability Corporation holds 0.33% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO) for 59,954 shares. Gw Henssler And Associate Limited stated it has 0.77% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). D E Shaw Communications accumulated 6,554 shares or 0% of the stock. Abner Herrman Brock Limited Liability Company owns 1.15% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 35,160 shares. Us Fincl Bank De reported 235,953 shares. Chevy Chase Trust holds 0.31% or 342,258 shares in its portfolio. Management Of Virginia Limited Liability Corp invested in 16,357 shares or 0.79% of the stock.

Since February 2, 2018, it had 0 insider buys, and 11 insider sales for $48.68 million activity. 1,000 shares were sold by Parrett William G, worth $209,796. $1.05M worth of Thermo Fisher Scientific Inc. (NYSE:TMO) was sold by Williamson Stephen on Wednesday, February 7. $44,174 worth of Thermo Fisher Scientific Inc. (NYSE:TMO) was sold by HARRIS C MARTIN. 33,327 shares were sold by Herrema Gregory J., worth $7.32M. $1.31M worth of Thermo Fisher Scientific Inc. (NYSE:TMO) was sold by Durbin Patrick M.

Pictet Asset Management Ltd increased its stake in Thermo Fisher Scientific Inc (TMO) by 4.41% based on its latest 2018Q1 regulatory filing with the SEC. Pictet Asset Management Ltd bought 122,108 shares as the company’s stock declined 0.20% with the market. The institutional investor held 2.89M shares of the industrial machinery and components company at the end of 2018Q1, valued at $596.95 million, up from 2.77 million at the end of the previous reported quarter. Pictet Asset Management Ltd who had been investing in Thermo Fisher Scientific Inc for a number of months, seems to be bullish on the $83.55 billion market cap company. The stock decreased 0.54% or $1.13 during the last trading session, reaching $207.67. About 153,192 shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 23.57% since June 21, 2017 and is uptrending. It has outperformed by 11.00% the S&P500.

Pictet Asset Management Ltd, which manages about $40.54 billion US Long portfolio, decreased its stake in Xilinx Inc (NASDAQ:XLNX) by 128,652 shares to 3.19 million shares, valued at $230.18M in 2018Q1, according to the filing. It also reduced its holding in Dominion Energy Inc (NYSE:D) by 698,000 shares in the quarter, leaving it with 2.71M shares, and cut its stake in Baxter Intl Inc (NYSE:BAX).

More news for Thermo Fisher Scientific Inc. (NYSE:TMO) were recently published by: Seekingalpha.com, which released: “Thermo Fisher Scientific (TMO) Investor Presentation – Slideshow” on May 25, 2018. Seekingalpha.com‘s article titled: “Thermo Fisher launches Ion AmpliSeq HD technology” and published on June 18, 2018 is yet another important article.

Thermo Fisher Scientific Inc. (NYSE:TMO) Ratings Coverage

Among 9 analysts covering Thermo Fisher (NYSE:TMO), 8 have Buy rating, 0 Sell and 1 Hold. Therefore 89% are positive. Thermo Fisher has $250 highest and $216 lowest target. $233.33’s average target is 12.36% above currents $207.67 stock price. Thermo Fisher had 12 analyst reports since January 3, 2018 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, January 31 by Cowen & Co. The firm has “Buy” rating by Bank of America given on Thursday, February 1. The rating was maintained by Morgan Stanley on Thursday, April 26 with “Overweight”. The stock has “Buy” rating by Evercore on Wednesday, January 3. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Buy” rating given on Wednesday, January 31 by Robert W. Baird. As per Thursday, February 1, the company rating was maintained by Jefferies. On Thursday, February 1 the stock rating was maintained by Leerink Swann with “Buy”. The stock has “Overweight” rating by Morgan Stanley on Thursday, February 1. The rating was maintained by Barclays Capital on Thursday, February 1 with “Overweight”. The firm has “Overweight” rating given on Wednesday, April 11 by Morgan Stanley.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: